Terms of Service

Last updated: January 25, 2026

1. Service Description

AI-in-Bio provides an agentic AI platform for drug discovery and proteomics research to qualified institutional partners during our private evaluation phase.

2. Institutional Access

Access to our platform is currently limited to Tier-1 research institutions and pharmaceutical companies participating in our private evaluation program. Access is granted by invitation only.

3. Intellectual Property

All platform technology, AI models, and software remain the property of AI-in-Bio. Research results generated using the platform are owned by the institutional partner, subject to agreed-upon terms.

4. Contact

For questions about these terms, contact legal@ai-in-bio.com